Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial

2007533 citationsJournal Articlegreen Open Access

Authors

Jack Cuzick · Guy's Hospital

JF Forbes · Tampere University

Ivana Šestak · Tampere University

Simon Cawthorn · Cancer Research UK

H. Hamed · Cancer Research UK

K Holli · Cancer Research UK

Anthony Howell · Breast Cancer Trials

Abstract

The risk-reducing effect of tamoxifen appears to persist for at least 10 years, but most side effects of tamoxifen do not continue after the 5-year treatment period.

Topics & Keywords

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JNCI Journal of the National Cancer Institute

Volume 99, Issue 4, pp. 272-282

DOI: 10.1093/jnci/djk049

Field-Weighted Citation Impact: 28.53